# Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer

> **NCT00809458** · PHASE3 · TERMINATED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 15 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Vitamin E

## Key facts

- **NCT ID:** NCT00809458
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2010-05
- **Final completion:** 2013-02
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Low rate of accrual.
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809458, "Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00809458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*